Combination of Cinrebafusp Alfa with Ramucirumab and Paclitaxel is Well Tolerated and Elicits Encouraging Clinical Activity in Patients with HER2-positive Gastric/gastroesophageal Junction (GEJ) Adenocarcinoma
CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要